Chargement en cours...
Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants
BACKGROUND: Persistent patent ductus arteriosus (PDA) is associated with mortality and morbidity in preterm infants. Prostaglandin synthetase inhibitors such as indomethacin promote PDA closure but also have potential side effects. The effect of the prophylactic use of indomethacin, where infants wh...
Enregistré dans:
| Publié dans: | Cochrane Database Syst Rev |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2010
|
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045285/ https://ncbi.nlm.nih.gov/pubmed/20614421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000174.pub2 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|